Wyen C, Jonsson-Oldenbuttel C, Noe S, Borch J, et al. Cabotegravir+rilpivirine long-acting every 2 months in a real-world setting: 24-month outcomes in people with HIV-1. AIDS 2026 Jan 20. doi: 10.1097/QAD.0000000000004448.
PMID: 41556989